Skip to main content

Want a detailed portfolio tracker?

GlucoTrack (GCTK) P/E (2019 - 2026)

GlucoTrack (GCTK) P/E from Apr 1, 2019 to Jul 20, 2026. The TTM GlucoTrack (GCTK) P/E is -0.01. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of GlucoTrack (GCTK)

YearP/EChange
2026-0.01-89.43%
2025-0.13-85.01%
2024-0.86-81.68%
2023-4.71-92.27%
2022-60.96-70.29%
2021-205.19-40.41%
2020-344.36-192.69%
2019371.53N/A

Comparison GlucoTrack (GCTK) P/E with competitors

GlucoTrack (GCTK) P/E is -0.01.

TickerNameP/EUpside
MHUAMeihua International Medical Technologies Co Ltd - Class A0.22-1736.79%
EMBCEmbecta Corp1.69-12455.99%
SOLVSolventum Corp9.49-69489.32%
ZJYLJin Medical International Ltd12.75-93283.12%
PDEXPro-Dex Inc (co)15.22-111358.02%
RMDResmed Inc19.04-139325.31%
UTMDUtah Medical Products Inc20.76-151860.40%
ATRAptargroup Inc21.65-158348.36%
ALGNAlign Technology Inc30.29-221542.14%
HOLXHologic Inc30.86-225726.60%
MMSIMerit Medical Systems Inc31.15-227788.86%
STVNStevanato Group Spa31.25-228578.38%
LMATLemaitre Vascular Inc36.34-265761.12%
ALCAlcon Inc41.51-303587.91%
ISRGIntuitive Surgical Inc46.43-339499.39%
BDXBecton Dickinson & Company46.93-343188.20%
WSTWest Pharmaceutical Services Inc47.41-346665.74%
NEPHNephros Inc50.00-365590.83%
COOCooper Companies Inc58.98-431252.60%
NNNNAnbio Biotechnology - Class A62.20-454797.85%
NVSTEnvista Holdings Corp64.66-472814.99%
BAXBaxter International Inc72.66-531242.41%
ICUIICU Medical Inc84.82-620166.51%
RGENRepligen Corp162.20-1185814.61%
WRBYWarby Parker Inc - Class A318.30-2326973.95%